Aakash R Sheth, MD

120 posts

Aakash R Sheth, MD

Aakash R Sheth, MD

@AakashRSheth

Cardiology Fellow @UPMCHHCVFellow @HVIUPMC|Former Internal Medicine resident @LSUHS|Racket Sports and Cricket|Tech Stuff

가입일 Ağustos 2020
454 팔로잉397 팔로워
Aakash R Sheth, MD 리트윗함
Udhayvir Grewal
Udhayvir Grewal@UGrewalMD·
@StefanoByer ⭐️ soon to be PGY3 IM resident @IntMedatIowa led this important work on outcomes of patients with ATTR cardiac amyloidosis and cardiac arrhythmias. @drpaari @UIowaCVFellows Dr Byer is applying to cardiology 🫀 fellowship this year and any program would be extremely lucky to have him. 💯
HeartRhythm@hrs_journal

Impact of SGLT2 Inhibitors on the Outcomes of Patients with Cardiac Arrythmias and Transthyretin Cardiac Amyloidosis @StefanoByer @UGrewalMD @drpaari heartrhythmjournal.com/article/S1547-…

English
0
4
10
868
Udhayvir Grewal
Udhayvir Grewal@UGrewalMD·
Excited to share that I will be joining @WinshipAtEmory (Atlanta, GA) as a GI/NET Medical Oncologist. I feel fortunate to finally have the opportunity to live the dream of caring for patients with GI and neuroendocrine cancers. Grateful to mentors and colleagues @UIowaCancer for everything. Thrilled to start my career at a time when our field is so rapidly evolving 🚀 🔥 Here’s hoping I will be able to make a difference in the lives of the people I cross paths with 🙏 🎗️🦓 @EmoryUniversity
Udhayvir Grewal tweet mediaUdhayvir Grewal tweet media
English
36
15
205
16K
Aakash R Sheth, MD
Aakash R Sheth, MD@AakashRSheth·
LBBAP compared to BiV pacing produced 1. ⬇️ composite endpoints: all-cause mortality and HFH 2. Greater ⬆️ in LVEF 3. ⬇️ arrhythmic risk Great start but we need larger RCTs. #LBCT #HRS2025
Aakash R Sheth, MD tweet mediaAakash R Sheth, MD tweet mediaAakash R Sheth, MD tweet media
English
0
0
7
427
Ahmed Ghoneem, MD MSc
Ahmed Ghoneem, MD MSc@a_h_ghoneem·
The most hardworking fellow I’ve met, and today’s grand rounds was more proof of that! @PittCardiology are lucky to have you @AakashRSheth !
UPMC Harrisburg CV Fellowship@UPMCHHCVFellow

Our ⭐️ third-year fellow @AakashRSheth presenting a fantastic grand rounds today on the history of atrial fibrillation management, and how we got to where we are at today. @AakashRSheth will be joining @PittCardiology next July for his EP fellowship & we are so proud of him!

English
1
0
1
485
Aakash R Sheth, MD
Aakash R Sheth, MD@AakashRSheth·
Truly grateful for the incredible mentorship and camaraderie here @UPMCHHCVFellow It’s been an honor to learn and grow alongside such an amazing team.
UPMC Harrisburg CV Fellowship@UPMCHHCVFellow

Our ⭐️ third-year fellow @AakashRSheth presenting a fantastic grand rounds today on the history of atrial fibrillation management, and how we got to where we are at today. @AakashRSheth will be joining @PittCardiology next July for his EP fellowship & we are so proud of him!

English
0
3
10
1.1K
Udhayvir Grewal
Udhayvir Grewal@UGrewalMD·
Congratulations @AakashRSheth Truly one of the most hardworking and talented people who I’m so proud to call my friend. @HviUpmc is so fortunate to have you!
Aakash R Sheth, MD@AakashRSheth

I am thrilled to announce that I will be continuing my training as an Electrophysiology Fellow at UPMC Presbyterian-Shadyside @PittCardiology @HviUpmc. I am deeply grateful to my mentors and friends at @UPMCHHCVFellow for their guidance and support along the way!

English
1
0
3
423
Aakash R Sheth, MD
Aakash R Sheth, MD@AakashRSheth·
I am thrilled to announce that I will be continuing my training as an Electrophysiology Fellow at UPMC Presbyterian-Shadyside @PittCardiology @HviUpmc. I am deeply grateful to my mentors and friends at @UPMCHHCVFellow for their guidance and support along the way!
Aakash R Sheth, MD tweet media
English
3
5
83
7.1K
Aakash R Sheth, MD
Aakash R Sheth, MD@AakashRSheth·
Twitter used to be one of the most efficient ways to connect within the #MedTwitter #EPeeps community. Restrictions on DM without being forced to be a verified/paid customer of Twitter (unfortunately called “X”now) is one of the many reasons to switch to @bluesky .
English
0
1
2
238
Udhayvir Grewal
Udhayvir Grewal@UGrewalMD·
Grateful to @SabarishMD and Dr Rastogi for the opportunity to author my first book chapter (also my first fellowship project at @UIowaCancer) on “Anemia of Inflammation” in “Non-Neoplastic Hematologic Disorders” published by @SpringerNature Link to the book (also strongly recommend considering as a companion for quick reference on Heme consults)- link.springer.com/book/10.1007/9…
Udhayvir Grewal tweet mediaUdhayvir Grewal tweet media
English
4
3
23
1.8K
Aakash R Sheth, MD 리트윗함
Henry Han
Henry Han@HanCardiomd·
#AFib ablation in end-stage HF : Lessons from CASTLE-HTx 📍In end-stage HF pt with AF, catheter ablation reduced AF burden by 36.3 pts & improved LVEF from 29.2% to 39.1% at 12 months (p < 0.001) 📍Persistent AF also dropped significantly (34.8% vs baseline; p = 0.0001). onlinelibrary.wiley.com/doi/10.1002/ej… @ESC_Journals #EJHF @EJHFEiC #Ablation #HeartFailure
Henry Han tweet mediaHenry Han tweet mediaHenry Han tweet media
EJHF Editor-in-Chief@EJHFEiC

Effects of #AFib ablation on #arrhythmia burden and ventricular function in end-stage heart failure: Lessons from #CASTLE-HTx Full 📝👇🏻@ESC_Journals onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

English
0
6
6
3.2K
Aakash R Sheth, MD 리트윗함
Allen Amorn MD
Allen Amorn MD@AllenAmornMD·
Very important work. So many patients don’t get optimal imaging because of fear of adverse events with CIEDs. We need @HRSonline @Cardiology to advocate for changes to CIED and MRI labeling. MagnaSafe registry is over a decade old now with no changes in federal law!
Roderick Tung@DrRoderickTung

In Press: The Banner – University Medical Center experience with MRI in Patients with Cardiovascular Implantable Electronic Devices and Fractured or Abandoned Leads pubs.rsna.org/doi/10.1148/ry…

English
0
3
8
1.6K
Aakash R Sheth, MD
Aakash R Sheth, MD@AakashRSheth·
Future superstar NET specialist and dear friend @UGrewalMD writes about the adverse events associated with Lutathera!! Should be an excellent read for all NET enthusiasts!
Udhayvir Grewal@UGrewalMD

🔥Hot off the press- Happy to share our real world post-marketing pharmacovigilance analysis on hematological toxicities (focus on MDS/AML) with Lutathera (Lu177-DOTA-TATE) in 🇺🇸 . 👉🏽Post-marketing surveillance data from the @US_FDA (2018-2023) 👉🏽 3443 adverse events, 243 (7.1%) were hematologic 👉🏽 majority thrombocytopenia, leukopenia, anemia and pancytopenia 👉🏽 MDS & AML comprised 2% of the reported events each. 👉🏽For context we compare the reporting of hematological toxicities (esp MDS and AML) with topoisomerase inhibitors 👉🏽This is a helpful reference that may potentially inform discussions with patients planning to receive PRRT (now referred to as radioligand therapy or RLT). Limitations- captures only 🇺🇸 data and the events reported to @US_FDA. Thank you @thakre_anuj for your help with the project. Link- link.springer.com/article/10.100…

English
1
2
13
778
Aakash R Sheth, MD
Aakash R Sheth, MD@AakashRSheth·
We will presenting our work on the impact of #GLP1RA in post-AF ablation patients at #HRS24 on Sunday, May 19. Here is the @CardiologyToday article covering our research. @harsh_cardio @SaurabhSDani @abhishek_mbbs @DrDeese99 @TheRhythmDoc @drpaari @UPMCHHCVFellow @HviUpmc
Cardiology Today@CardiologyToday

In patients with type 2 diabetes who underwent ablation for #afib, those taking a GLP-1 receptor agonist had lower risk for AF recurrence, mortality and other outcomes #HRS2024 @HRSonline @AakashRSheth @HviUpmc #Cardiotwitter #EPeeps Read more👇 healio.com/news/cardiolog…

English
2
7
18
4K

탐색

@StefanoByer @IntMedatIowa @drpaari @UIowaCVFellows @UGrewalMD @WinshipAtEmory @UIowaCancer @SagarLonialMD